cilengitide has been researched along with Hyperplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joner, M; Kapp, TG; Kessler, H; Laufer, B; Li, L; Mas-Moruno, C; Neubauer, S; Rechenmacher, F; Steigerwald, K | 1 |
1 other study(ies) available for cilengitide and Hyperplasia
| Article | Year |
|---|---|
The integrin ligand c(RGDf(NMe)Nal) reduces neointimal hyperplasia in a polymer-free drug-eluting stent system.
Topics: Animals; Cell Line; Cell Proliferation; Disease Models, Animal; Drug-Eluting Stents; Hyperplasia; Immunosuppressive Agents; Integrins; Oligopeptides; Polymers; Rabbits; Snake Venoms; Wound Healing | 2014 |